{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T10:22:55Z","timestamp":1776680575481,"version":"3.51.2"},"reference-count":159,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jceh.2013.09.001","type":"journal-article","created":{"date-parts":[[2013,9,17]],"date-time":"2013-09-17T03:48:22Z","timestamp":1379389702000},"page":"231-242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["MicroRNAs in Liver Disease: Bench to Bedside"],"prefix":"10.1016","volume":"3","author":[{"given":"Nihar","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kris V.","family":"Kowdley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2013.09.001_bib1","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jceh.2013.09.001_bib2","doi-asserted-by":"crossref","first-page":"D152","DOI":"10.1093\/nar\/gkq1027","article-title":"MiRBase: integrating miR annotation and deep-sequencing data","volume":"39","author":"Kozomara","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jceh.2013.09.001_bib3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ng1536","article-title":"Combinatorial microRNA target predictions","volume":"37","author":"Krek","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.jceh.2013.09.001_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are miR targets","volume":"120","author":"Lewis","year":"2005","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jceh.2013.09.001_bib5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res"},{"key":"10.1016\/j.jceh.2013.09.001_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1476-4598-8-102","article-title":"MiRs in colorectal cancer: translation of molecular biology into clinical application","volume":"8","author":"Slaby","year":"2009","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jceh.2013.09.001_bib7","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature09783","article-title":"Pervasive roles of miRs in cardiovascular biology","volume":"469","author":"Small","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jceh.2013.09.001_bib8","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MiR expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jceh.2013.09.001_bib9","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","article-title":"Identification of tissue-specific miRs from mouse","volume":"12","author":"Lagos-Quintana","year":"2002","journal-title":"Curr Biol"},{"key":"10.1016\/j.jceh.2013.09.001_bib10","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3748\/wjg.15.1665","article-title":"MiR signatures in liver diseases","volume":"15","author":"Chen","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2013.09.001_bib11","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1126\/science.1113329","article-title":"Modulation of hepatitis C virus RNA abundance by liver-specific miR","volume":"309","author":"Jopling","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jceh.2013.09.001_bib12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4161\/rna.1.2.1066","article-title":"MiR-122, a mammalian liver-specific miR, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1","volume":"1","author":"Chang","year":"2004","journal-title":"RNA Biol"},{"key":"10.1016\/j.jceh.2013.09.001_bib13","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/hep.22749","article-title":"Expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma","volume":"49","author":"Ura","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2013.09.001_bib14","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/hep.22569","article-title":"Nonalcoholic steatohepatitis is associated with altered hepatic miR expression","volume":"48","author":"Cheung","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2013.09.001_bib15","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1093\/nar\/gkq601","article-title":"Export of miRs and miR protective protein by mammalian cells","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jceh.2013.09.001_bib16","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of miRs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases","volume":"10","author":"Chen","year":"2008","journal-title":"Cell Res"},{"key":"10.1016\/j.jceh.2013.09.001_bib17","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1517\/14712590902932889","article-title":"MiR identification in plasma and serum: a new tool to diagnose and monitor diseases","volume":"9","author":"Cortez","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jceh.2013.09.001_bib18","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1073\/pnas.0813371106","article-title":"Circulating miRs, potential biomarkers for drug-induced liver injury","volume":"106","author":"Wang","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jceh.2013.09.001_bib19","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3851\/IMP2401","article-title":"Plasma miR profile as a predictor of early virological response to interferon treatment in chronic hepatitis B patients","volume":"17","author":"Zhang","year":"2012","journal-title":"Antivir Ther"},{"issue":"37","key":"10.1016\/j.jceh.2013.09.001_bib20","first-page":"5188","article-title":"Serum levels of miRs can specifically predict liver injury of chronic hepatitis B","volume":"18","author":"Zhang","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2013.09.001_bib21","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/hep.25873","article-title":"Circulating miRs in exosomes indicates hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases","volume":"56","author":"Bala","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2013.09.001_bib22","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating miRs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jceh.2013.09.001_bib23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ymeth.2010.01.032","article-title":"Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)","volume":"50","author":"Kroh","year":"2010","journal-title":"Methods"},{"key":"10.1016\/j.jceh.2013.09.001_bib24","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1101\/gr.2722704","article-title":"Identification of mammalian microRNA host genes and transcription units","volume":"14","author":"Rodriguez","year":"2004","journal-title":"Genome Res"},{"issue":"3","key":"10.1016\/j.jceh.2013.09.001_bib25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ncb0309-228","article-title":"Many roads to maturity: microRNA biogenesis pathways and their regulation","volume":"11","author":"Winter","year":"2009","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jceh.2013.09.001_bib26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature01957","article-title":"The nuclear RNase III Drosha initiates miR processing","volume":"425","author":"Lee","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jceh.2013.09.001_bib27","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1101\/gad.1158803","article-title":"Exportin-5 mediates the nuclear export of pre-miRs and short hairpin RNAs","volume":"17","author":"Yi","year":"2003","journal-title":"Genes Dev"},{"key":"10.1016\/j.jceh.2013.09.001_bib28","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal miRs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jceh.2013.09.001_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MiRs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jceh.2013.09.001_bib30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MiRs: genomics, biogenesis, mechanisms and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jceh.2013.09.001_bib31","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/hep.23344","article-title":"Therapeutic RNA manipulation in liver disease","volume":"51","author":"Kerr","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2013.09.001_bib32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molcel.2007.06.017","article-title":"MiR targeting specificity in mammals: determinants beyond seed pairing","volume":"27","author":"Grimson","year":"2007","journal-title":"Mol Cell"},{"key":"10.1016\/j.jceh.2013.09.001_bib33","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.4161\/cbt.8.18.8898","article-title":"New kids on the block: diagnostic and prognostic miRs in hepatocellular carcinoma","volume":"8","author":"Ji","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jceh.2013.09.001_bib34","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/hep.23818","article-title":"Liver-enriched transcription factors regulate micro-RNA 122 that target CUTL1 during liver development","volume":"52","author":"Xu","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2013.09.001_bib35","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1872-034X.2010.00683.x","article-title":"Quantitative analysis of miR expression in several developmental stages of human livers","volume":"40","author":"Liu","year":"2010","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jceh.2013.09.001_bib36","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.3748\/wjg.v17.i20.2536","article-title":"MiRs: fad or future of liver disease","volume":"17","author":"Lakner","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2013.09.001_bib37","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jhep.2008.01.019","article-title":"MiR-122, a paradigm\u00a0for\u00a0the role of miRs in the liver","volume":"48","author":"Girard","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2013.09.001_bib38","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.4161\/cc.8.10.8349","article-title":"Activation of hepatitis C virus translation by a liver specific miR","volume":"8","author":"Niepmann","year":"2009","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.jceh.2013.09.001_bib39","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1172\/JCI44883","article-title":"The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice","volume":"121","author":"Castoldi","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jceh.2013.09.001_bib40","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1038\/onc.2009.211","article-title":"Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties","volume":"28","author":"Coulouarn","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.jceh.2013.09.001_bib41","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1373\/clinchem.2010.147850","article-title":"Plasma micro-RNA-122 as a biomarker for viral, alcohol and chemical related hepatic diseases","volume":"56","author":"Zhang","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.jceh.2013.09.001_bib42","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.virol.2010.11.015","article-title":"Competing roles of miR-122 recognition elements in hepatitis C virus RNA","volume":"410","author":"Nasheri","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.jceh.2013.09.001_bib43","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1128\/JVI.00417-10","article-title":"Regulation of hepatitis C virus translation and infectious virus production by the micro-RNA miR-122","volume":"84","author":"Jangra","year":"2010","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jceh.2013.09.001_bib44","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/msb.2010.58","article-title":"MiR-122 as a regulator of mitochondrial metabolic gene network in hepato-cellular carcinoma","volume":"6","author":"Burchard","year":"2010","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.jceh.2013.09.001_bib45","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2174\/187152011796011037","article-title":"MiR involvement in hepatocellular carcinoma","volume":"11","author":"Negrini","year":"2011","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.jceh.2013.09.001_bib46","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/hep.24538","article-title":"Circulating miRs as potential markers of human drug induced liver injury","volume":"5","author":"Starkey Lewis","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2013.09.001_bib47","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/ajg.2011.161","article-title":"Serum miR-122 as a biomarker of necro-inflammation in patients with chronic hepatitis C virus infection","volume":"106","author":"Bihrer","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2013.09.001_bib48","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1111\/j.1365-2893.2011.01536.x","article-title":"Serum miR 122 levels in different groups of patients with chronic hepatitis B virus infection","volume":"19","author":"Waidmann","year":"2012","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jceh.2013.09.001_bib49","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mc.20712","article-title":"Circulating miRs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis","volume":"50","author":"Xu","year":"2011","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.jceh.2013.09.001_bib50","doi-asserted-by":"crossref","first-page":"e23937","DOI":"10.1371\/journal.pone.0023937","article-title":"Circulating miRs in patients with chronic hepatitis C and non-alcoholic fatty liver disease","volume":"6","author":"Cermelli","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2013.09.001_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2013.05.021","article-title":"Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver","author":"Yamada","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jceh.2013.09.001_bib52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","article-title":"MiR-122 regulation of lipid metabolism revealed by in\u00a0vivo antisense targeting","volume":"3","author":"Esau","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.jceh.2013.09.001_bib53","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1440-1746.2011.06864.x","article-title":"Transition from hepatic steatosis to steatohepatitis: unique miR patterns and potential downstream functions and pathways","volume":"27","author":"Jin","year":"2012","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2013.09.001_bib54","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1172\/JCI63455","article-title":"MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis","volume":"122","author":"Tsai","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jceh.2013.09.001_bib55","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.dld.2008.08.008","article-title":"MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease","volume":"41","author":"Jin","year":"2009","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jceh.2013.09.001_bib56","doi-asserted-by":"crossref","first-page":"9798","DOI":"10.1158\/0008-5472.CAN-10-1001","article-title":"Serum miR profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma","volume":"70","author":"Li","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.jceh.2013.09.001_bib57","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nature06205","article-title":"Interferon modulation of cellular microRNAs as an antiviral mechanism","volume":"449","author":"Pedersen","year":"2007","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.jceh.2013.09.001_bib58","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.3390\/v4112485","article-title":"MicroRNAs, hepatitis C virus, and HCV\/HIV-1 Co-infection: new insights in pathogenesis and therapy","volume":"4","author":"Gupta","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.jceh.2013.09.001_bib59","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.virol.2009.11.036","article-title":"Systematic identification of miR and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells","volume":"398","author":"Liu","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.jceh.2013.09.001_bib60","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.bbrc.2005.09.183","article-title":"Targets for human encoded miRs in HIV genes","volume":"337","author":"Hariharan","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jceh.2013.09.001_bib61","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/nm1639","article-title":"Cellular miRs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes","volume":"13","author":"Huang","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jceh.2013.09.001_bib62","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/317489a0","article-title":"The hepatitis B virus","volume":"317","author":"Tiollais","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.jceh.2013.09.001_bib63","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1440-1746.2002.02737.x","article-title":"Hepatitis B viral genotypes: clinical relevance and molecular characteristics","volume":"17","author":"Kao","year":"2002","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2013.09.001_bib64","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1053\/j.gastro.2009.08.061","article-title":"Factors that predict response of patients with hepatitis B e antigen positive chronic hepatitis B to pegylated interferon-alfa","volume":"137","author":"Buster","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2013.09.001_bib65","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1111\/j.1365-2893.2011.01443.x","article-title":"Circulating miRs in hepatitis B virus-infected patients","volume":"18","author":"Ji","year":"2011","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jceh.2013.09.001_bib66","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12072-009-9140-3","article-title":"HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B","volume":"3","author":"Liaw","year":"2009","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2013.09.001_bib67","doi-asserted-by":"crossref","DOI":"10.1186\/1743-422X-8-354","article-title":"Ectopic expression of miR-155 enhances innate antiviral immunity against HBV infection in human hepatoma cells","volume":"8","author":"Su","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.jceh.2013.09.001_bib68","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1200\/JCO.2011.38.2697","article-title":"Plasma miR panel to diagnose hepatitis B virus-related hepatocellular carcinoma","volume":"29","author":"Zhou","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jceh.2013.09.001_bib69","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.antiviral.2010.08.008","article-title":"Suppression of hepatitis B virus replication by miR-199a-3p and miR-210","volume":"88","author":"Zhang","year":"2010","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jceh.2013.09.001_bib70","first-page":"2128","article-title":"Differential micro RNA expression profile of HepG2 cells induced by HBV integration","volume":"29","author":"Han","year":"2007","journal-title":"J\u00a0Third Mil Med Univ"},{"key":"10.1016\/j.jceh.2013.09.001_bib71","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jhep.2009.12.043","article-title":"Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3","volume":"53","author":"Wang","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2013.09.001_bib72","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.bbrc.2011.06.191","article-title":"MiR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma","volume":"411","author":"Wang","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jceh.2013.09.001_bib73","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bbrc.2010.07.021","article-title":"MiR-122-induced downregulation of HO-1 negatively affects miR-122-mediated suppression of HBV","volume":"4","author":"Qiu","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jceh.2013.09.001_bib74","doi-asserted-by":"crossref","first-page":"12884","DOI":"10.1073\/pnas.0704894104","article-title":"Cellular cofactors affecting hepatitis C virus infection and replication","volume":"104","author":"Randall","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jceh.2013.09.001_bib75","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/labinvest.2010.126","article-title":"Correlation between miR expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans","volume":"90","author":"Marquez","year":"2010","journal-title":"Lab Invest"},{"key":"10.1016\/j.jceh.2013.09.001_bib76","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.24016","article-title":"MiR silencing of tumor suppressor DLC-1 promotes efficient hepatitis C virus replication in primary human hepatocytes","volume":"53","author":"Banaudha","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2013.09.001_bib77","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/ijc.25143","article-title":"Functional screening identifies a miR, miR-491 that induces apoptosis by targeting Bcl-X (L) in colorectal cancer cells","volume":"127","author":"Nakano","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jceh.2013.09.001_bib78","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bbrc.2011.07.049","article-title":"Alterations in miR expression profile in HCV-infected hepatoma cells: involvement of miR-491 in regulation of HCV replication via the PI3 kinase\/Akt pathway","volume":"412","author":"Ishida","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jceh.2013.09.001_bib79","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1101\/gr.2845604","article-title":"MiR expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues","volume":"14","author":"Barad","year":"2004","journal-title":"Genome Res"},{"key":"10.1016\/j.jceh.2013.09.001_bib80","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1261\/rna.498607","article-title":"A\u00a0simple array platform for miR analysis and its application in mouse tissues","volume":"13","author":"Tang","year":"2007","journal-title":"RNA"},{"key":"10.1016\/j.jceh.2013.09.001_bib81","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1755-8794-3-48","article-title":"Hepatic miR expression is associated with the response to interferon treatment of chronic hepatitis C","volume":"3","author":"Murakami","year":"2010","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.jceh.2013.09.001_bib82","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2008.06.010","article-title":"Regulation of the hepatitis C virus genome replication by miR-199a","volume":"50","author":"Murakami","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2013.09.001_bib83","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/hep.23401","article-title":"MiR-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins","volume":"51","author":"Hou","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2013.09.001_bib84","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/infdis\/jir186","article-title":"Hepatitis C virus infection and hepatic stellate cell activation down-regulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture","volume":"203","author":"Bandyopadhyay","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jceh.2013.09.001_bib85","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/hep.25849","article-title":"Hepatitis C virus-induced upregulation of miR-155 promotes hepatocarcinogenesis by activating Wnt signaling","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.jceh.2013.09.001_bib86","doi-asserted-by":"crossref","first-page":"e50826","DOI":"10.1371\/journal.pone.0050826","article-title":"Hepatitis C virus mediated changes in miR-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway","volume":"7","author":"Sarma","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2013.09.001_bib87","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1178178","article-title":"Therapeutic silencing of miR-122 in primates with chronic hepatitis C virus infection","volume":"327","author":"Lanford","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jceh.2013.09.001_bib88","series-title":"A\u00a0Randomized, Double-blind, Placebo Controlled Safety and Antiviral Proof of Concept Study of Miravirsen (MIR), an Oligonucleotide Targeting MIR-122, in Treatment Na\u00efve Patients with Genotype 1 (GT1) Chronic HCV Infection","author":"Janssen","year":"2011"},{"key":"10.1016\/j.jceh.2013.09.001_bib89","series-title":"Miravirsen, an Oligonucleotide Targeting Micro-RNA-122, Induces a Decline of Interferon-gamma Inducible Protein-10 in Treatment Na\u00efve Chronic Hepatitis C Genotype 1 Patients","author":"Adriaan","year":"2012"},{"key":"10.1016\/j.jceh.2013.09.001_bib90","series-title":"Miravirsen, a Novel Anti-HCV Therapeutic Targeting the Host Cell Factor miR-122, Demonstrates Broad Antiviral Activity Against Drug Resistant HCV Variants","author":"Patrick","year":"2012"},{"key":"10.1016\/j.jceh.2013.09.001_bib91","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nm.1902","article-title":"Decreased levels of miR-122 in individuals with hepatitis C responding poorly to interferon therapy","volume":"15","author":"Sarasin-Filipowicz","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.jceh.2013.09.001_bib92","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/1743-422X-7-311","article-title":"Differential expression of interferon-induced miRs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha","volume":"7","author":"Scagnolari","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.jceh.2013.09.001_bib93","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/pgmj.2004.026005","article-title":"Acute liver failure","volume":"81","author":"O'Grady","year":"2005","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jceh.2013.09.001_bib94","first-page":"527","article-title":"The role of miR-122 expression during the acute liver failure in mice induced by D-GalN\/LPS","volume":"18","author":"An","year":"2010","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1016\/j.jceh.2013.09.001_bib95","first-page":"1428","article-title":"Circulating miR-122 as a potential biomarker for liver injury","volume":"5","author":"Ding","year":"2012","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jceh.2013.09.001_bib96","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.24809","article-title":"Loss of miR122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1)-modulated P53 activity","volume":"55","author":"Wang","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2013.09.001_bib97","first-page":"549","article-title":"The expression profile and roles of miR in tumor necrosis factor-\u03b1 mediated acute liver failure in mouse model","volume":"28","author":"An","year":"2010","journal-title":"Chin J Infect Dis"},{"key":"10.1016\/j.jceh.2013.09.001_bib98","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1478-3231.2009.02181.x","article-title":"Acute liver injury upregulates miR-491-5p in mice, and its overexpression sensitizes Hep G2 cells for tumor necrosis factor-alpha-induced apoptosis","volume":"30","author":"Yoon","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2013.09.001_bib99","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.24243","article-title":"MiR-221 regulates FAS-induced fulminant liver failure","volume":"53","author":"Sharma","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2013.09.001_bib100","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3109\/15563650903438566","article-title":"Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 26th annual report","volume":"47","author":"Bronstein","year":"2009","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.jceh.2013.09.001_bib101","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2036.2009.04175.x","article-title":"Review article: the current management of acute liver failure","volume":"3","author":"Craig","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2013.09.001_bib102","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1478-3231.2011.02501.x","article-title":"Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity","volume":"1","author":"Jaeschke","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2013.09.001_bib103","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1101\/gad.1781009","article-title":"Integration of miR miR-122 in hepatic circadian gene expression","volume":"23","author":"Gatfield","year":"2009","journal-title":"Genes Dev"},{"key":"10.1016\/j.jceh.2013.09.001_bib104","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute 2 complexes carry a population of circulating miRs independent of vesicles in human plasma","volume":"108","author":"Arroyo","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jceh.2013.09.001_bib105","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/clpt.2012.40","article-title":"The effects of heparins on the liver: application of mechanistic serum biomarkers in a randomized study in healthy volunteers","volume":"92","author":"Harrill","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jceh.2013.09.001_bib106","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.3748\/wjg.15.5633","article-title":"Emerging role of miRs in liver diseases","volume":"15","author":"Bala","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2013.09.001_bib107","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1542\/peds.62.5S.898","article-title":"Acetaminophen overdose: incidence, diagnosis, and management in 416 patients","volume":"62","author":"Rumack","year":"1978","journal-title":"Pediatrics"},{"key":"10.1016\/j.jceh.2013.09.001_bib108","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3109\/15563650.2010.523828","article-title":"When do the aminotransferases rise after acute acetaminophen overdose?","volume":"48","author":"Green","year":"2010","journal-title":"Clin Toxicol (Phila)"},{"issue":"22","key":"10.1016\/j.jceh.2013.09.001_bib109","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.3748\/wjg.v18.i22.2798","article-title":"Plasma miR profiles distinguish lethal injury in acetaminophen toxicity: a research study","volume":"18","author":"Ward","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2013.09.001_bib110","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3748\/wjg.v16.i11.1321","article-title":"Alcoholic liver disease and the gut-liver axis","volume":"16","author":"Szabo","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2013.09.001_bib111","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1074\/jbc.M110.145870","article-title":"Up-regulation of miR-155 in macrophages contributes to increased tumor necrosis factor (alpha) production via increased mRNA half-life in alcoholic liver disease","volume":"2","author":"Bala","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jceh.2013.09.001_bib112","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1530-0277.2009.01126.x","article-title":"MiRs: master regulators of ethanol abuse and toxicity?","volume":"34","author":"Miranda","year":"2010","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"10.1016\/j.jceh.2013.09.001_bib113","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ajpath.2012.06.010","article-title":"Epigenetic regulation of miR-34a expression in alcoholic liver injury. Biomarkers, genomics, pro and gene regulation","volume":"181","author":"Meng","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jceh.2013.09.001_bib114","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1530-0277.2007.00584.x","article-title":"Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease","volume":"32","author":"Tang","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jceh.2013.09.001_bib115","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.4049\/jimmunol.0901084","article-title":"Ethanol-induced expression of ET-1 and ET-BR in liver sinusoidal endothelial cells and human endothelial cells involves hypoxia-inducible factor-1alpha and miR-199","volume":"183","author":"Yeligar","year":"2009","journal-title":"J\u00a0Immunol"},{"issue":"10","key":"10.1016\/j.jceh.2013.09.001_bib116","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1530-0277.2009.01007.x","article-title":"MiR expression profile in Lieber-Decarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice","volume":"33","author":"Dolganiuc","year":"2009","journal-title":"Alcoholism"},{"key":"10.1016\/j.jceh.2013.09.001_bib117","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/498232","article-title":"MiR signature in alcoholic liver disease","author":"Bala","year":"2012","journal-title":"Int J Hepatol"},{"issue":"8","key":"10.1016\/j.jceh.2013.09.001_bib118","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ni.f.209","article-title":"MiRs: new regulators of immune cell development and function","volume":"9","author":"Baltimore","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jceh.2013.09.001_bib119","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1530-0277.2010.01398.x","article-title":"The unfolding web of innate immune dysregulation in alcoholic liver injury","volume":"35","author":"Szabo","year":"2011","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jceh.2013.09.001_bib120","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1530-0277.2009.00946.x","article-title":"Nitric oxide mediated intestinal injury is required for alcohol-induced gut leakiness and liver damage","volume":"33","author":"Tang","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"issue":"5","key":"10.1016\/j.jceh.2013.09.001_bib121","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cmet.2012.04.004","article-title":"Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease","volume":"15","author":"Min","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.jceh.2013.09.001_bib122","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/labinvest.2010.113","article-title":"Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice","volume":"90","author":"Pogribny","year":"2010","journal-title":"Lab Invest"},{"key":"10.1016\/j.jceh.2013.09.001_bib123","doi-asserted-by":"crossref","first-page":"G887","DOI":"10.1152\/ajpgi.00216.2010","article-title":"Identification of miRs during fat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acid","volume":"299","author":"Castro","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jceh.2013.09.001_bib124","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.bbrc.2009.05.058","article-title":"The up-regulation of miR-335 is associated with lipid metabolism in liver and white adipose tissue of genetically obese mice","volume":"385","author":"Nakanishi","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jceh.2013.09.001_bib125","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1440-1746.2009.05949.x","article-title":"Effect of miR-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD","volume":"25","author":"Zheng","year":"2010","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2013.09.001_bib126","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s10495-005-1055-4","article-title":"The role and regulation of hepatic stellate cells apoptosis in reversal of liver fibrosis","volume":"10","author":"El-Sharkawy","year":"2005","journal-title":"Apoptosis"},{"key":"10.1016\/j.jceh.2013.09.001_bib127","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.5858\/2007-131-1728-HSCALF","article-title":"Hepatic stellate cells and liver fibrosis","volume":"131","author":"Moreira","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jceh.2013.09.001_bib128","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cbi.2011.07.001","article-title":"Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches","volume":"193","author":"Mormone","year":"2011","journal-title":"Chem Biol Interact"},{"issue":"2","key":"10.1016\/j.jceh.2013.09.001_bib129","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"3","key":"10.1016\/j.jceh.2013.09.001_bib130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00109-003-0517-9","article-title":"The role of epithelial-to-mesenchymal transition in renal fibrosis","volume":"82","author":"Zeisberg","year":"2004","journal-title":"J\u00a0Mol Med (Berl)"},{"issue":"1","key":"10.1016\/j.jceh.2013.09.001_bib131","doi-asserted-by":"crossref","first-page":"e16081","DOI":"10.1371\/journal.pone.0016081","article-title":"The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families","volume":"6","author":"Murakami","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2013.09.001_bib132","doi-asserted-by":"crossref","first-page":"G101","DOI":"10.1152\/ajpgi.00220.2009","article-title":"Liver fibrosis causes downregulation of miR-150 and miR-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation","volume":"1","author":"Venugopal","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jceh.2013.09.001_bib133","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2009.10.002","article-title":"MeCP2 controls an epigenetic pathway that promotes myofibroblast trans-differentiation and fibrosis","volume":"138","author":"Mann","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2013.09.001_bib134","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.febslet.2009.01.034","article-title":"Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation","volume":"583","author":"Ji","year":"2009","journal-title":"FEBS Lett"},{"issue":"4","key":"10.1016\/j.jceh.2013.09.001_bib135","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jhep.2008.11.025","article-title":"Mir-15b and Mir-16 are implicated in activation of the rat hepatic stellate cell: an essential role for apoptosis","volume":"50","author":"Guo","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2013.09.001_bib136","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbrc.2012.03.025","article-title":"MiR-181b promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients","volume":"421","author":"Wang","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jceh.2013.09.001_bib137","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1258\/ebm.2010.010231","article-title":"The potential of microRNAs in liver fibrosis","volume":"236","author":"Fu","year":"2011","journal-title":"Exp Biol Med (Maywood, N.J.)"},{"key":"10.1016\/j.jceh.2013.09.001_bib138","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.cellsig.2012.06.003","article-title":"MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4","volume":"24","author":"He","year":"2012","journal-title":"Cell Signal"},{"key":"10.1016\/j.jceh.2013.09.001_bib139","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.23922","article-title":"Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis","volume":"53","author":"Roderburg","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2013.09.001_bib140","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.bbrc.2009.11.056","article-title":"Suppression of type I collagen production by microRNA-29b in cultured human stellate cells","volume":"391","author":"Ogawa","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jceh.2013.09.001_bib141","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/labinvest.2012.70","article-title":"Expression of platelet-derived growth factor-C and insulin-like growth factor I in hepatic stellate cells is inhibited by miR-29","volume":"92","author":"Kwiecinski","year":"2012","journal-title":"Lab Invest"},{"issue":"9","key":"10.1016\/j.jceh.2013.09.001_bib142","doi-asserted-by":"crossref","first-page":"e45652","DOI":"10.1371\/journal.pone.0045652","article-title":"Serum miR-122 predicts survival in patients with liver cirrhosis","volume":"7","author":"Waidmann","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2013.09.001_bib143","doi-asserted-by":"crossref","first-page":"e32999","DOI":"10.1371\/journal.pone.0032999","article-title":"Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis","volume":"7","author":"Roderburg","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2013.09.001_bib144","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1053\/jlts.2001.23794","article-title":"Are post-transplantation protocol liver biopsies useful in the long term?","volume":"7","author":"Berenguer","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2013.09.001_bib145","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJM200102153440706","article-title":"Liver biopsy","volume":"344","author":"Bravo","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2013.09.001_bib146","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/lt.21117","article-title":"A\u00a0prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation","volume":"13","author":"Yilmaz","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2013.09.001_bib147","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/lt.21500","article-title":"Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2013.09.001_bib148","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/01.tp.0000270313.31328.63","article-title":"Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C","volume":"84","author":"Rayhill","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2013.09.001_bib149","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1089-3261(03)00053-9","article-title":"To transplant or not to transplant recurrent hepatitis C and liver failure","volume":"7","author":"Forman","year":"2003","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.jceh.2013.09.001_bib150","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/ajt.12047","article-title":"MiR signature at the time of clinical HCV recurrence associates with aggressive fibrosis post-liver transplantation","volume":"13","author":"Gehrau","year":"2013","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jceh.2013.09.001_bib151","doi-asserted-by":"crossref","first-page":"e26971","DOI":"10.1371\/journal.pone.0026971","article-title":"Serum miR-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma","volume":"6","author":"Bihrer","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2013.09.001_bib152","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/lt.22438","article-title":"Hepatocyte-derived miRs as serum biomarker of hepatic injury and rejection after liver transplantation","volume":"18","author":"Farid","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2013.09.001_bib153","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1373\/clinchem.2010.157198","article-title":"Analysis of circulating miR: preanalytical and analytical challenges","volume":"57","author":"McDonald","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.jceh.2013.09.001_bib154","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/SLA.0b013e3181cc939f","article-title":"Circulating miRs as novel minimally invasive biomarkers for breast cancer","volume":"251","author":"Heneghan","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.jceh.2013.09.001_bib155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1586\/erm.10.106","article-title":"Tissular and soluble miRs for diagnostic and therapy improvement in digestive tract cancers","volume":"11","author":"Albulescu","year":"2011","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.jceh.2013.09.001_bib156","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3816\/CLC.2011.n.001","article-title":"Circulating miRs: possible prediction biomarkers for personalized therapy of non-small-cell lung carcinoma","volume":"12","author":"Gao","year":"2011","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jceh.2013.09.001_bib157","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1349-7006.2010.01650.x","article-title":"Circulating miR in body fluid: a new potential biomarker for cancer diagnosis and prognosis","volume":"101","author":"Kosaka","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jceh.2013.09.001_bib158","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.aca.2011.05.025","article-title":"Analytical aspects of miR in diagnostics: a review","volume":"699","author":"Planell-Saguer","year":"2011","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.jceh.2013.09.001_bib159","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00216-009-2744-6","article-title":"Trends in miR detection","volume":"394","author":"Cissell","year":"2009","journal-title":"Anal Bioanal Chem"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688313006105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688313006105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:01:47Z","timestamp":1760853707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688313006105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":159,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0973688313006105"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2013.09.001","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNAs in Liver Disease: Bench to Bedside","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2013.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 INASL. Published by Elsevier, a division of Reed Elsevier India, Pvt. Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}